[go: up one dir, main page]

WO1998037180A3 - Protease hybride du vhc et polynucleotide codant cette derniere - Google Patents

Protease hybride du vhc et polynucleotide codant cette derniere Download PDF

Info

Publication number
WO1998037180A3
WO1998037180A3 PCT/US1998/003367 US9803367W WO9837180A3 WO 1998037180 A3 WO1998037180 A3 WO 1998037180A3 US 9803367 W US9803367 W US 9803367W WO 9837180 A3 WO9837180 A3 WO 9837180A3
Authority
WO
WIPO (PCT)
Prior art keywords
encoding same
polynucleotide encoding
protease
hcv fusion
fusion protease
Prior art date
Application number
PCT/US1998/003367
Other languages
English (en)
Other versions
WO1998037180A2 (fr
Inventor
Chih-Ming Chen
Akhteruzzaman Molla
Rakesh L Tripathi
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of WO1998037180A2 publication Critical patent/WO1998037180A2/fr
Publication of WO1998037180A3 publication Critical patent/WO1998037180A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
    • C12N9/506—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses derived from RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Cette invention concerne des protéines hybrides biologiquement actives de la protéase NS3 du virus de l'hépatite C et la protéine du cofacteur NS4A, qui sont non autoclivables, ainsi que des polynucléotides codant ces dernières; des vecteurs d'expression comprenant les polynucléotides et des cellules hôtes transformées avec ces mêmes polynucléotides; et un procédé permettant d'identifier des composés d'inhibiteur de la protéase NS3 du virus de l'hépatite C à l'aide des protéines hybrides de cette invention.
PCT/US1998/003367 1997-02-22 1998-02-20 Protease hybride du vhc et polynucleotide codant cette derniere WO1998037180A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80426697A 1997-02-22 1997-02-22
US08/804,266 1997-02-22

Publications (2)

Publication Number Publication Date
WO1998037180A2 WO1998037180A2 (fr) 1998-08-27
WO1998037180A3 true WO1998037180A3 (fr) 1998-11-19

Family

ID=25188568

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1998/003367 WO1998037180A2 (fr) 1997-02-22 1998-02-20 Protease hybride du vhc et polynucleotide codant cette derniere

Country Status (1)

Country Link
WO (1) WO1998037180A2 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7223743B2 (en) 2000-08-17 2007-05-29 Tripep Ab Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
US7226912B2 (en) 2000-08-17 2007-06-05 Tripep Ab Hepatitis C virus non-structural NS3/4A fusion gene
US7244422B2 (en) 2000-08-29 2007-07-17 Tripep Ab Vaccines containing ribavirin and methods of use thereof
US8883169B2 (en) 2007-08-16 2014-11-11 Chrontech Pharma Ab Immunogen platform

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6280940B1 (en) 1998-08-05 2001-08-28 Agouron Pharmaceuticals, Inc. Reporter gene system for use in cell-based assessment of inhibitors of the Hepatitis C virus protease
WO2001002601A2 (fr) * 1999-07-07 2001-01-11 Du Pont Pharmaceuticals Company Systemes de dosage cellulaire destines a l'examen de l'activite de la protease ns3 hcv
US7244721B2 (en) 2000-07-21 2007-07-17 Schering Corporation Peptides as NS3-serine protease inhibitors of hepatitis C virus
KR20030081297A (ko) 2000-07-21 2003-10-17 쉐링 코포레이션 Ｃ형 간염 바이러스의 ｎｓ3-세린 프로테아제억제제로서의 신규한 펩티드
MXPA03000627A (es) 2000-07-21 2004-07-30 Schering Corp Nuevos peptidos como inhibidores de proteasa serina-ns3 del virus de la hepatitis c.
WO2002013855A2 (fr) * 2000-08-17 2002-02-21 Tripep Ab Vaccins contenant de la ribavirine et procedes d'utilisation associes
CN108239656A (zh) * 2016-12-27 2018-07-03 天津天锐生物科技有限公司 一种小分子药物控制的蛋白功能开关系统
JP2022518488A (ja) * 2019-01-25 2022-03-15 センティ バイオサイエンシズ インコーポレイテッド タンパク質機能を制御するための融合構築物

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995022985A1 (fr) * 1994-02-23 1995-08-31 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. Procede de reproduction in vitro de l'activite proteolytique de la protease ns3 du virus de l'hepatite c (vhc)
WO1996036702A2 (fr) * 1995-05-12 1996-11-21 Schering Corporation Protease active soluble du virus de l'hepatite c

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995022985A1 (fr) * 1994-02-23 1995-08-31 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. Procede de reproduction in vitro de l'activite proteolytique de la protease ns3 du virus de l'hepatite c (vhc)
WO1996036702A2 (fr) * 1995-05-12 1996-11-21 Schering Corporation Protease active soluble du virus de l'hepatite c

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
"GST Gene Fusion Vectors", PHARMCIA BIOTECH '95 '96 CATALOGUE, 1994, pages 118 - 119, XP002077832 *
KOLYKHALOV, A.A. ET AL.: "Specificity of the Hepatitis C Virus NS3 serine protease: Effects of substitutions at the 3/4A, 4A/4B, 4B/5A, and 5A/5B cleavage sites on polyprotein processing", JOURNAL OF VIROLOGY, vol. 68, no. 11, November 1994 (1994-11-01), pages 7525 - 7533, XP002077834 *
STEINKÜHLER, C. ET AL.: "Activity of purified Hepatitis C Virus protease NS3 on peptide substrates", JOURNAL OF VIROLOGY, vol. 70, no. 10, October 1996 (1996-10-01), pages 6694 - 6700, XP002077833 *

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7223743B2 (en) 2000-08-17 2007-05-29 Tripep Ab Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
US7226912B2 (en) 2000-08-17 2007-06-05 Tripep Ab Hepatitis C virus non-structural NS3/4A fusion gene
US7241440B2 (en) 2000-08-17 2007-07-10 Tripep Ab Vaccines containing ribavirin and methods of use thereof
US7307066B2 (en) 2000-08-17 2007-12-11 Tripep Ab Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
US7439347B2 (en) 2000-08-17 2008-10-21 Tripep Ab Hepatitis C virus non-structural NS3/4A fusion gene
US7638499B2 (en) 2000-08-17 2009-12-29 Tripep Ab Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
US7244422B2 (en) 2000-08-29 2007-07-17 Tripep Ab Vaccines containing ribavirin and methods of use thereof
US7261883B2 (en) 2000-08-29 2007-08-28 Tripep Ab Vaccines containing ribavirin and methods of use thereof
US8883169B2 (en) 2007-08-16 2014-11-11 Chrontech Pharma Ab Immunogen platform

Also Published As

Publication number Publication date
WO1998037180A2 (fr) 1998-08-27

Similar Documents

Publication Publication Date Title
AU7063598A (en) Hepatitis c ns3 protease inhibitors
ZA979327B (en) Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease.
DE60014345D1 (en) Makrozyklische peptide als hepatitis c virus ns3 protease inhibitore
WO1999038888A3 (fr) Inhibiteurs peptidiques de l'activite de la serine protease associee a la proteine ns53 de vhc, leurs utilisations correspondantes et leur procede de production
AU2933797A (en) Synthetic inhibitors of hepatitis c virus ns3 protease
WO1997033996A3 (fr) Bikunine humaine
WO1998037180A3 (fr) Protease hybride du vhc et polynucleotide codant cette derniere
HUT73384A (en) Methods of typing hepatitis c virus and reagents for use therein
PL347932A1 (en) Interferon-beta fusion proteins and uses
ATE317854T1 (de) Hepatitis c inhibitor peptide
WO2003027306A3 (fr) Beta-glucosidase bgl3 et acides nucleiques la codant
WO2003052054A3 (fr) Bgl5 béta-glucosidase et acides nucléiques codant ce dernier
AU8700291A (en) Hcv-specific peptides, agents therefor and the use thereof
AU7957898A (en) Nucleic acids encoding polypeptide having protease activity
DE69812773D1 (de) Methode zur de novo Peptidsequenz-Bestimmung
WO2003052118A3 (fr) Beta-glucosidase bgl4 et acides nucleiques la codant
AU6020598A (en) Dna sequences, vectors, and fusion polypeptides for secretion of polypeptides infilamentous fungi
DK0832258T3 (da) Opstrøms aktivatorsekvenser og rekombinante promotorsekvenser, der er funktionelle i Yarrowia og vektorer indeholdende disse
AU2197392A (en) Hepatitis C virus from C-100-3 and env/core regions
AU1905399A (en) Hepatitis c virus ns5b truncated protein and methods thereof to identify antiviral compounds
SI0932617T1 (en) Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease
AU7602800A (en) Hepatitis c virus envelope two protein (e2) which lacks all or part of the hypervariable region one (hvr1), corresponding nucleic acids, chimeric viruses and uses thereof
WO1999020760A3 (fr) Genes et proteine du canal a ions potassium de la famille erg humaine (herg)
WO2003002730A3 (fr) Methode de detection de l'activite de la calpaine 3 dans un echantillon biologique et peptides pour la mise en oeuvre de ladite methode
WO1995013386A3 (fr) Enzyme de fusion de la proteine activatrice de la tyrosinase

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): CA JP MX

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 1998536916

Format of ref document f/p: F

122 Ep: pct application non-entry in european phase